Interestingly, some reports have suggested that sestrin 2 expression can be elevated in some cancers, such as the non-small cell lung cancer (NSCLC) line A549, and that its expression is negatively correlated with lung cancer patient survival [55]. Here, SESN2 is linked to lung carcinoma.